Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Safety and Effects of VERT-002 for Patients with Advanced Solid Tumors, Including Lung Cancer with MET Alterations

    Recruiting

    2 1 1
    Investigated Drugs:
    Belgium France Germany Italy The Netherlands Spain
  • Study on PET Imaging with Fianlimab and Cemiplimab for Patients with Advanced Solid Tumors, with or without Platinum-Based Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Drugs:
    The Netherlands
  • Study on APL-101 for Treating Advanced Solid Tumors and Non-Small Cell Lung Cancer with MET Changes in Patients

    Recruiting

    1 1 1
    Investigated Drugs:
    France Hungary Italy Spain
  • Study Comparing ANV419 and High Dose IL2 in Adoptive Cell Therapy for Patients with Melanoma, Non-Small Cell Lung Cancer, and Cervical Cancer

    Recruiting

    2 1 1 1
    Denmark The Netherlands Spain
  • Study of IMP1734, Paclitaxel, and Abiraterone for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1
    Denmark France Spain
  • Study for Children and Adolescents with Recurrent or Relapsed Solid Tumors Using Lutetium (177Lu) Oxodotreotide and Olaparib

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Spain
  • Study on the Safety of Encorafenib, Binimetinib, and Ribociclib for Patients with Solid Tumors

    Recruiting

    3 1 1 1
    Czechia France Germany Greece Hungary Italy +4
  • Study on Treating Solid Tumors with Genetically Modified T-Cells (IMA203, IMA203CD8) and Nivolumab for Patients with Recurrent or Refractory Conditions

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Germany
  • Study of EGL-001 for Adults with Advanced or Metastatic Solid Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Spain
  • Study of Drug Combination Treatment Based on Tumor Molecular Changes in Patients with Advanced or Metastatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    France